Get startedLog in
    Picture of Halozyme Therapeutics logo

    HALO — Halozyme Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Halozyme Announces Global Collaboration And License Agreement With Takeda

    Picture of Halozyme Therapeutics logoHalozyme Therapeutics
    08/01/2026 13:32
    Jan 8 (Reuters) - Halozyme Therapeutics Inc HALO.O:

HALOZYME ANNOUNCES GLOBAL COLLABORATION AND LICENSE AGREEMENT WITH TAKEDA TO DEVELOP AND COMMERCIALIZE VEDOLIZUMAB WITH ENHANZE®

HALOZYME THERAPEUTICS INC - TAKEDA GAINS EXCLUSIVE ACCESS TO ENHANZE TECHNOLOGY

HALOZYME THERAPEUTICS INC - TAKEDA TO MAKE UPFRONT AND MILESTONE PAYMENTS TO HALOZYME

HALOZYME THERAPEUTICS INC - TO RECEIVE ROYALTIES ON VEDOLIZUMAB SALES

Source text: ID:nPn3V6yQa

Further company coverage: HALO.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Halozyme Therapeutics

    See all news